TLDR Male pattern hair loss is common, affects mental health, and can be treated with medication or hair transplants.
Male pattern hair loss, or androgenetic alopecia, affects 30-50% of men aged 20-25 and older, significantly impacting their quality of life and mental health. It is linked to various health issues, including skin cancer, cardiovascular diseases, and is heavily influenced by genetics, with heredity contributing 80% to its development. Treatments like minoxidil and finasteride can prevent further hair loss but have limited success in reversing baldness and require continuous use, with potential side effects such as sexual dysfunction and skin irritation. Hair transplantation offers a more lasting solution, achieving desirable results in up to 98% of cases.
Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.
A 24-year-old experienced improved hair growth using 5% minoxidil, 1 mg finasteride, and dermastamping, but faced side effects like low libido and mild erectile dysfunction. They plan to reduce finasteride dosage after full results and may consider a hair transplant if thinning recurs.
The user is using minoxidil, topical finasteride, Nizoral shampoo, and a dermaroller for hair regrowth but is experiencing changes in sexual function. They are concerned about whether these changes are due to the treatment and are seeking advice on continuing hair growth without affecting sexuality.
Male androgeneticalopecia is commonly treated with topical minoxidil and oral finasteride, both requiring continuous use. Other options include hair restoration surgery, dutasteride, light therapy, and camouflaging agents.
Finasteride and minoxidil are recommended as first-line treatments for hair loss, with dutasteride and oral minoxidil as stronger options if needed. Hair transplants should only be considered after achieving stability with medication, and non-surgical options are suggested if medications are ineffective.
Oral minoxidil, finasteride, and dutasteride are being used to treat hair loss, but results are limited, leading to consideration of a hair transplant. The user plans to continue medication for another year before deciding on further action.
The user achieved significant hair regrowth using oral and topical minoxidil, finasteride, microneedling, ashwagandha, and amla powder. They experienced some side effects like low libido from finasteride but reported no major issues with minoxidil.
The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.
